Diphtheria
📧 Sign up to get email alerts when something new happens for Diphtheria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants [Phase 3]
Phase 3 trial comparing the safety and immunogenicity of Pediacel versus Infanrix IPV+Hib (Penta) given in a 3-dose schedule in infants; the…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar® [Phase 3]
Phase 3 trial comparing booster vaccination with Pediacel versus Infanrix Hexa when co-administered with Prevenar in healthy infants has com…
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
A post-authorization safety study evaluating the Euforvac-Hib vaccine for active primary immunization in infants starting at 6 weeks to moni…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years [Phase 1]
Phase 1 safety and dose-ranging study of acellular pertussis vaccine and an acellular pertussis-tetanus-diphtheria booster vaccine in health…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-28Clinical Trial Update: Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial assessing safety and immunogenicity of booster doses for new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (GSK217744) in chi…
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Pertussis Vaccine in Healthy Pregnant Women [Phase 1]
Phase 1 trial evaluating a pertussis-containing vaccine in healthy pregnant women has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants [Phase 3]
A Phase 3 trial assessed the booster effect of the DTaP-IPV-HepB-PRP-T vaccine (Infanrix Hexa) and Prevenar in healthy infants; results were…
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject [Phase 3]
A Phase 3 clinical trial comparing the immunogenicity and safety of Quinvaxem vaccine given in mono-dose vials versus Uniject.
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 lot-consistency study of the DTaP-IPV-HB-PRP~T vaccine administered at 2-4-6 months in healthy infants has completed; results were…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants [Phase 3]
Phase 3 study evaluating the DTaP-IPV-Hep B-PRP-T vaccine given with Prevenar and Rotarix in healthy Latin American infants; results were po…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers [Phase 3]
Phase 3 safety trial of Infanrix-IPV+Hib vaccine in healthy Vietnamese toddlers completed with results posted
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV [Phase 3]
A Phase 3 trial comparing the DTaP-IPV-Hep B-PRP-T combined vaccine to CombAct-HIB given with Engerix B Paediatric and OPV; results were pos…
-
CLINICAL_TRIALS trial_result · 2014-04-30Clinical Trial Update: Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose [Phase 4]
This Phase 4 study reports immune responses in adults after revaccination with ADACEL (diphtheria, tetanus, and acellular pertussis) vaccine…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China [Phase 1]
Phase 1 study evaluating the ADACEL Tdap booster in healthy adults and children in China has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish Infants [Phase 3]
Phase 3 study assessing the immunogenicity and safety of a booster dose of the DTaP-IPV-HB-PRP~T combined vaccine in healthy Turkish infants…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-Hep B-PRP~T Combined Vaccine with Infanrix Hexa in healthy Peruvian infants; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-HB-PRP-T (Sanofi Pasteur) to Infanrix Hexa when co-administered with Prevnar in Thai infants; results were …
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents [Phase 1, Phase 2]
Clinical trial update for the ADACEL booster vaccine in adolescents (Phase 1/Phase 2) with results posted in 2014, evaluating safety and imm…
-
CLINICAL_TRIALS trial_result · 2014-02-14Clinical Trial Update: Immunogenicity and Safety of an Acellular DPT Vaccine During Pregnancy [Phase 2]
Phase 2 study assessing the immunogenicity and safety of an acellular DPT vaccine administered during pregnancy has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule [Phase 3]
Phase 3 trial assessing the immunogenicity of a combined DTaP-IPV-Hep B-PRP~T vaccine versus PENTAXIM and ENGERIX B in infants at 2- to 4-mo…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
This update summarizes safety findings related to reactogenicity of ADACEL (Tdap) vaccine in children and adolescents aged 7 to 19 years.
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® [Phase 2]
Phase 2 study evaluating PR5I, a pediatric combination vaccine with an enhanced Hepatitis B component, given concomitantly with Prevnar; the…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine
Post-marketing safety study of Boostrix vaccine has completed and summarizes safety monitoring for diphtheria, tetanus, and pertussis indica…